IL10 and acute pancreatitis: DCQD treatment could increase the expression of anti-inflammatory cytokines (IL-4 and IL-10) and inhibit the expression of proinflammatory cytokines (TNF-α and IL-6) to ameliorate the histopathological damage of acute pancreatitis, in which higher dose DCQD seems to have the better effect.